Screener
Sionna Therapeutics SION Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 4,809 | 5,537 |
| Total current assets | 220,959 | 241,419 |
| Property and equipment, net | 2,071 | 2,225 |
| Marketable securities, noncurrent | 73,781 | 74,420 |
| Restricted cash | 963 | 963 |
| Operating lease right-of-use asset | 6,680 | 6,926 |
| Other assets | 585 | — |
| Total assets | $305,039 | $325,953 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's long-term investments?
- Sionna Therapeutics (SION) reported long-term investments of $73.78M in Q1 2026.
- How has Sionna Therapeutics's long-term investments changed year-over-year?
- Sionna Therapeutics's long-term investments decreased by 13.2% year-over-year, from $85.02M to $73.78M.
- What does long-term investments mean?
- Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.
Ask your AI about Sionna Therapeutics's long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude